Comparison of a new MR rapid wash-out map with MR perfusion in brain tumors

IF 3.4 2区 医学 Q2 ONCOLOGY
Eya Khadhraoui, Leon Schmidt, Stefan Klebingat, Roland Schwab, Silvia Hernández-Durán, Georg Gihr, Harald Paukisch, Klaus-Peter Stein, Daniel Behme, Sebastian Johannes Müller
{"title":"Comparison of a new MR rapid wash-out map with MR perfusion in brain tumors","authors":"Eya Khadhraoui, Leon Schmidt, Stefan Klebingat, Roland Schwab, Silvia Hernández-Durán, Georg Gihr, Harald Paukisch, Klaus-Peter Stein, Daniel Behme, Sebastian Johannes Müller","doi":"10.1186/s12885-024-12909-z","DOIUrl":null,"url":null,"abstract":"MR perfusion is a standard marker to distinguish progression and therapy-associated changes after surgery and radiochemotherapy for glioblastoma. TRAMs (Treatment Response Assessment Maps) were introduced, which are intended to facilitate the differentiation of vital tumor cells and radiation necrosis by means of late (20–90 min) contrast clearance and enhancement. The differences of MR perfusion and late-enhancement are not fully understood yet. We have implemented and established a fully automated creation of rapid wash-out (15–20 min interval) maps in our clinic. We included patients with glioblastoma, CNS lymphoma or brain metastases who underwent our MR protocol with MR perfusion and rapid wash-out between 01/01/2024 and 30/06/2024. Since both wash-out and hyperperfusion are intended to depict the active tumor area, this study involves a quantitative and qualitative comparison of both methods. For this purpose, we volumetrically measured rCBV (relative cerebral blood volume) maps and rapid wash-out maps separately (two raters). Additionally, we rated the agreement between both maps on a Likert scale (0–10). Thirty-two patients were included in the study: 15 with glioblastoma, 7 with CNS lymphomas and 10 with brain metastasis. We calculated 36 rapid wash-out maps (9 initial diagnosis, 27 follow-up). Visual agreement of MR perfusion with rapid wash-out by rating were found in 44 ± 40% for initial diagnosis, and 75 ± 31% for follow-up. We found a strong correlation (Pearson coefficient 0.92, p < 0.001) between the measured volumes of MR perfusion and rapid wash-out. The measured volumes of MR perfusion and rapid wash-out did not differ significantly. Small lesions were often not detected by MR perfusion. Nevertheless, the measured volumes showed no significant differences in this small cohort. Rapid wash-out calculation is a simple tool that provides new information and, when used in conjunction with MR perfusion, may increase diagnostic accuracy. The method shows promising results, particularly in the evaluation of small lesions.","PeriodicalId":9131,"journal":{"name":"BMC Cancer","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12885-024-12909-z","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

MR perfusion is a standard marker to distinguish progression and therapy-associated changes after surgery and radiochemotherapy for glioblastoma. TRAMs (Treatment Response Assessment Maps) were introduced, which are intended to facilitate the differentiation of vital tumor cells and radiation necrosis by means of late (20–90 min) contrast clearance and enhancement. The differences of MR perfusion and late-enhancement are not fully understood yet. We have implemented and established a fully automated creation of rapid wash-out (15–20 min interval) maps in our clinic. We included patients with glioblastoma, CNS lymphoma or brain metastases who underwent our MR protocol with MR perfusion and rapid wash-out between 01/01/2024 and 30/06/2024. Since both wash-out and hyperperfusion are intended to depict the active tumor area, this study involves a quantitative and qualitative comparison of both methods. For this purpose, we volumetrically measured rCBV (relative cerebral blood volume) maps and rapid wash-out maps separately (two raters). Additionally, we rated the agreement between both maps on a Likert scale (0–10). Thirty-two patients were included in the study: 15 with glioblastoma, 7 with CNS lymphomas and 10 with brain metastasis. We calculated 36 rapid wash-out maps (9 initial diagnosis, 27 follow-up). Visual agreement of MR perfusion with rapid wash-out by rating were found in 44 ± 40% for initial diagnosis, and 75 ± 31% for follow-up. We found a strong correlation (Pearson coefficient 0.92, p < 0.001) between the measured volumes of MR perfusion and rapid wash-out. The measured volumes of MR perfusion and rapid wash-out did not differ significantly. Small lesions were often not detected by MR perfusion. Nevertheless, the measured volumes showed no significant differences in this small cohort. Rapid wash-out calculation is a simple tool that provides new information and, when used in conjunction with MR perfusion, may increase diagnostic accuracy. The method shows promising results, particularly in the evaluation of small lesions.
新型磁共振快速冲洗图与脑肿瘤磁共振灌注图的比较
磁共振灌注是区分胶质母细胞瘤手术和放化疗后进展和治疗相关变化的标准标记。TRAM(治疗反应评估图)的出现旨在通过晚期(20-90 分钟)造影剂清除和增强来区分重要的肿瘤细胞和放射坏死。磁共振灌注和晚期增强的差异尚未完全明了。我们已在诊所实施并建立了全自动快速冲洗(间隔 15-20 分钟)图谱。我们纳入了 2024 年 1 月 1 日至 2024 年 6 月 30 日期间接受磁共振灌注和快速冲洗的胶质母细胞瘤、中枢神经系统淋巴瘤或脑转移患者。由于冲洗和高灌注都是为了描述活跃的肿瘤区域,本研究对这两种方法进行了定量和定性比较。为此,我们分别对 rCBV(相对脑血流量)图和快速冲洗图进行了容积测量(两名评分员)。此外,我们还用李克特量表(0-10)对两种地图之间的一致性进行了评分。研究共纳入 32 名患者:其中 15 人患有胶质母细胞瘤,7 人患有中枢神经系统淋巴瘤,10 人患有脑转移瘤。我们计算了 36 张快速冲洗图(9 张初始诊断图,27 张随访图)。初步诊断时,核磁共振灌注与快速冲洗评分的目测一致率为 44 ± 40%,随访时为 75 ± 31%。我们发现磁共振灌注和快速冲洗的测量体积之间存在很强的相关性(皮尔逊系数 0.92,p < 0.001)。磁共振灌注和快速冲洗的测量体积没有明显差异。磁共振灌注通常无法检测到小病灶。尽管如此,在这个小规模队列中,测得的体积并无明显差异。快速冲洗计算是一种提供新信息的简单工具,与磁共振灌注结合使用可提高诊断准确性。该方法显示出良好的效果,尤其是在评估小病灶时。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMC Cancer
BMC Cancer 医学-肿瘤学
CiteScore
6.00
自引率
2.60%
发文量
1204
审稿时长
6.8 months
期刊介绍: BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信